Atlas Reserve Precious Metals LLC is a Wyoming-registered precious metals dealer focused on transparent pricing, physical delivery options, and secure depository storage for self-directed retirement investors. The company provides access to IRS-eligible bullion products, allocated storage solutions, and rollover support services for qualified retirement accounts, founded on the principle that physical gold and silver should be accessible, understandable, and fairly priced for Americans seeking to diversify their retirement portfolios with tangible assets.
Cheyenne, Wyoming, United States, 21st May 2026 – Atlas Reserve Precious Metals LLC, a Wyoming-registered precious metals dealer, has announced the official launch of its physical gold and silver bullion platform designed for self-directed Gold IRAs and Silver IRAs. The company provides access to IRS-eligible gold and silver coins and bars, supported by transparent spot-plus-premium pricing and allocated storage through U.S.-based depositories.
The platform was developed to provide a straightforward process for individuals seeking to include physical precious metals within self-directed retirement account structures. Atlas Reserve supports rollovers from eligible retirement accounts, including traditional IRAs, Roth IRAs, and 401(k) plans, with dedicated support throughout the account transfer process.
“Atlas Reserve gives American investors a simple, transparent way to allocate a portion of their 401(k) or IRA into physical precious metals”
said Diren Tercanoglu, Director and Founder of Atlas Reserve Precious Metals LLC.
“IRS-eligible gold and silver bullion at true low markups, combined with secure allocated storage and the flexibility of physical delivery – that is the foundation of what Atlas Reserve offers. The goal is to make real, physical assets accessible without the high fees or complexity that have historically made Gold IRAs difficult for everyday investors.”
Gold IRA and Silver IRA Platform Features
Atlas Reserve provides IRS-approved gold and silver coins and bars eligible for self-directed retirement accounts. Pricing follows a transparent spot-plus-premium structure with no undisclosed fees, offering investors clear visibility into premiums and transaction costs. The platform supports seamless rollover processing from 401(k)s, traditional IRAs, Roth IRAs, and other qualified plans. Storage is fully allocated and insured through leading U.S. depositories, with physical delivery available for investors who prefer direct possession.
401(k) to Gold IRA Rollover Guide
To support investors navigating the rollover process, Atlas Reserve has published a free educational resource covering eligibility requirements, IRS rules, custodian selection, and step-by-step rollover procedures. The guide is available at:
Atlas Reserve Precious Metals LLC is a Wyoming-registered precious metals dealer focused on transparent pricing, physical delivery options, and secure depository storage for self-directed retirement investors. The company provides access to IRS-eligible bullion products, allocated storage solutions, and rollover support services for qualified retirement accounts, founded on the principle that physical gold and silver should be accessible, understandable, and fairly priced for Americans seeking to diversify their retirement portfolios with tangible assets.
Niihara International, Inc. has launched a new corporate website and received SEC qualification of its Regulation A+ Tier 2 offering to support development and commercialization of therapies, including L‑glutamine for sickle cell disease and other unmet medical needs.
Irvine, California, United States, 21st May 2026– Niihara International, Inc. (“Niihara International” or the “Company”), today announced the launch of its new corporate website at www.niiharainternational.com and the qualification by the U.S. Securities and Exchange Commission (“SEC”) of the Company’s Regulation A+ Tier 2 offering of common stock. The Company is a pharmaceutical access company focused on expanding access to proven therapies for serious and underserved medical conditions.
The new website is designed to provide investors, patients, healthcare professionals, and other stakeholders with streamlined access to information about the Company’s business, product development plans, corporate governance and investor materials. The site features dedicated sections for corporate information, regulatory filings, and updates regarding Niihara International’s efforts to develop and commercialize innovative therapies, including its initial product candidate, a generic prescription-grade L‑glutamine oral powder for sickle cell disease.
Niihara International’s Regulation A+ Tier 2 offering has been qualified by the SEC pursuant to the Company’s Offering Circular, which is available on the SEC’s EDGAR system. Under the qualified offering, the Company is offering shares of its common stock on a “best efforts” basis, with the proceeds intended to fund product development, clinical, regulatory and commercialization activities, as well as general corporate purposes.
The Offering Circular and related information about the offering can be accessed by visiting the SEC’s website and searching for Niihara International, Inc. (CIK 0002062360) or via the Company’s own website via the link to its subscription portal provided below. Prospective investors are urged to carefully review the Offering Circular, including the section titled “Risk Factors,” and all other documents incorporated by reference before making any investment decision.
“This is an important milestone for Niihara International as we advance our strategy to develop and deliver therapies for patients with serious unmet medical needs,” said Founder and CEO Yutaka Niihara. “The launch of our new website and the qualification of our Regulation A+ Tier 2 offering provide a foundation to communicate more effectively with investors and partners as we seek to execute on our growth plans.”
The securities described in the Offering Circular are being offered pursuant to Regulation A under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offering of securities will be made only by means of the Offering Circular and related subscription materials.
About Niihara International, Inc.
Niihara International, Inc., incorporated in California in 2023, is a development-stage biopharmaceutical company focused on the development, commercialization and distribution of innovative therapies. The Company is also focused on expanding access to proven therapies for serious and underserved medical conditions.
The Company’s initial product is a generic prescription-grade L‑glutamine oral powder designed to reduce acute complications associated with sickle cell disease in patients ages five years and older. For more information, please visit www.niiharainternational.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the Company’s business strategy, development plans, product candidates, potential markets, and the anticipated use of proceeds of the Regulation A+ Tier 2 offering. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including those described under “Risk Factors” in the Offering Circular and in other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and Niihara International, Inc. undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date hereof.
This Enterprise Unveils Industrial High-Purity Lipid Raw Material Product Portfolio for Global Fine Chemical Clients
Guangzhou, Guangdong, China, 21st May 2026 – Guangzhou Hanfang Pharmaceutical Company Limited. (a subsidiary of Guangzhou Pharmaceutical Holdings Limited) today announced updates to its industrial lipid raw material product portfolio and global service upgrades. The company’s offerings include industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), tailored to meet industrial production requirements across multiple regions. Adopting a comprehensive business model encompassing direct sales, distribution, custom processing, and technical support, the enterprise serves over 1,000 clients worldwide with a business network spanning more than 20 countries and regions, further expanding its global fine chemical supply chain footprint.
Core Product Portfolio and Technical Services
Guangzhou Baiyunshan Hanfang Pharmaceutical provides products and services tailored for industrial fine chemical enterprises and related industries:
Industrial High-Purity Lipid Raw Materials: Supplies industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), serving as core components for emulsifiers, cosolvents, and industrial energy additive raw materials, complying with process standards for industrial production scenarios.
Customization and Technical Support: Delivers customized solutions for exclusive raw material formulation needs, including compliant adjustments to component ratios and performance parameters; the technical team provides end-to-end guidance on production process applications.
Comprehensive Business Model: Covers direct sales, authorized distribution, custom processing, and technical services, meeting diverse needs from standard orders to customized projects.
Global Compliance and Quality Standards
The enterprise has established operational and quality systems aligned with international fine chemical supply chain norms. Its production base in Conghua, Guangzhou, adopts fully controlled end-to-end processes to ensure consistent product quality. Products are sold across Asia, Europe, and other regions, with efficient delivery enabled by mature logistics channels.
Supply and Service Information
Products are available globally through the direct sales team and authorized distributors. Orders are accepted from industrial fine chemical enterprises and related manufacturers, with standard production lead times provided. Custom processing services are available for premium clients, alongside formulation technical consultations. Clients may inquire via the official website or regional sales representatives.
“We focus on ensuring the stability of the fine chemical supply chain, with deep expertise in the lipid raw material sector,” said Chen Shiqi, Project Manager at Guangzhou Baiyunshan Hanfang Pharmaceutical. “We are committed to delivering stable, reliable products and technical support to meet the evolving needs of our global clients.”
Industry Background and Strategic Direction
Industry data indicates sustained growth in global demand for high-quality industrial lipid raw materials, driven primarily by the expansion of global fine chemical production capacity and the need for supply chain resilience. As a member enterprise of Guangzhou Pharmaceutical Holdings Limited, Baiyunshan Hanfang closely follows trends in the fine chemical supply chain industry, focusing on product stability and global technical services to support the growth of clients worldwide.
Future Plans
Guangzhou Baiyunshan Hanfang Pharmaceutical will continue to increase investment in production capacity and product R&D, with plans to expand its global distribution network, upgrade technical service systems for international clients, and prioritize meeting the diverse production needs of core markets.
About Guangzhou Hanfang Pharmaceutical Company Limited
Founded in 1998 and headquartered in Guangzhou, Guangzhou Hanfang Pharmaceutical Company Limited employs more than 330 people across production, R&D, quality control, and administration. The enterprise specializes in industrial fine chemical raw materials, lipid raw materials, and supporting technical services, with products sold in over 20 countries and regions. It holds multiple patents for lipid processing technologies, with its Conghua production base serving as the core production hub. The enterprise’s mission is “stable supply, technical collaboration, empowering the global fine chemical industry.” For more information, please visit the official website: https://www.byshanhanfang.com/
Media Contact
Organization: Guangzhou Hanfang Pharmaceutical Company Limited
United States, 21st May 2026 – Renowned energy strategist and highly experienced business leader Gareth Evans has released his book, Powering Profits: Control Energy Costs, Build Resilience, and Gain a Lasting Competitive Advantage. The new book is an invaluable corporate leadership guide that offers a deep dive into how power systems work and urges businesses to rethink their energy strategy. It provides actionable strategies for business leaders to reduce costs and gain a competitive advantage.
Powering Profits is an insightful executive playbook that provides a strategic framework for CEOs, business leaders, and entrepreneurs to prioritize control, enhance adaptability, and achieve measurable financial outcomes by reimagining their energy strategy. At a time when energy policies and political issues are reshaping the global business landscape, the new book serves as a timely educational resource, highlighting the business risks of relying on aging energy systems that are not only overburdened by rapid business expansion but also vulnerable to extreme weather events and supply chain disruptions. Drawing on years of experience and research across complex energy systems in various industries, the author illuminates a path forward in which self-managed energy can not only protect organizations from disruptions and rising costs but also offer a strategic advantage over time, turning energy into a scalable asset.
Gareth Evans is passionate about helping businesses generate clean, on-site energy that is reliable, affordable, and a powerful asset that drives growth and revenue. Having worked and lived across six continents, he has seen firsthand how centralized energy systems are unreliable and unfair. As the CEO and co-founder of VECKTA, he has dedicated his professional life to empowering businesses to own their power, delivering solutions that improve operational efficiency and create long-term value.
In addition to authoring the Powering Profits Substack, Gareth is the co-host of the Renewable Rides podcast, where he shares his expertise with executives and CEOs across industries. He has worked with globally recognized companies, including Worley, a global leader in reshaping energy solutions.
Gareth Evans is available for interviews.
Title: Powering Profits: Control Energy Costs, Build Resilience, and Gain a Lasting
United States, 21st May 2026 – Certified Financial Planner practitioner and wealth management expert Brian K. Peterson has released his book, Blended Family Finances: How to Talk About Money, Plan for the Future, and Build a Life You Love. The new book is a transformative financial planning guide for blended families. It offers a deeply human approach to long-term money management that also accounts for relationships and family values.
Blended Family Finances is a timely guide for today’s evolving family structures, addressing the unique issues blended families face. It offers a flexible roadmap rooted in communication and shared purpose, providing clarity and support to families after loss, divorce, or remarriage. Through real-life stories, the book outlines three key steps: having open conversations about money, creating a shared vision, and using practical strategies for protection. It emphasizes emotional aspects often overlooked in traditional financial planning, filling an important gap.
Brian K. Peterson is a Certified Financial Planner practitioner and a Certified Private Wealth Advisor® with a passion for helping blended families plan for a stable, secure financial future. As a dad in a blended family, his personal experience complements his professional expertise, enabling him to help families achieve their financial goals through meaningful communication and intentional living. Widely known as “The Financial Planner for Blended Families™,” he is the founder of Blended Family Financial.
Over the years, Brian has developed his proprietary framework, the Planning Built for Life® process, which helps couples move beyond traditional planning and navigate money matters with confidence and unity. His new book combines his unique philosophy with practical financial knowledge, empowering families to create a better life.
Brian K. Peterson CFP® is available for interviews.
Title: Blended Family Finances: How to Talk About Money, Plan for the Future,
Borders Tree Services, a locally owned tree service company based in Sonora, TX, is celebrating 15 years of professional tree care across Sutton County and Crockett County.
Sonora, TX 76950, United States, 21st May 2026 – Managing property in West Texas requires resilience, especially given the volatile weather patterns of the Edwards Plateau. In communities like Sonora, Ozona, and Rocksprings, a single severe storm season can devastate local landscapes and property values. Recognizing a widespread need for reliable, region-specific tree care, Borders Tree Services launched to provide residents with dependable, locally rooted expertise. Today, the company remains a trusted partner in safeguarding the natural beauty and property investments of West Texas communities.
Over the past 15 years, the company has built a full-service operation rooted in regional expertise. They offer tree trimming, removal, stump grinding, stump removal, cutting, and emergency response across their service area. An experienced arborist leads every project on-site. Work is completed on schedule, with clients kept informed at every stage. A satisfaction follow-up after project completion reflects the company’s standard of accountability. From Big Lake to Eden and Eldorado, their arborists bring deep knowledge of native species. They also help diagnose and treat regional tree diseases like Oak Wilt and Hypoxylon Canker.
A senior member of the team spoke about what the milestone means, “Fifteen years in Sutton County teaches things no classroom can. Every property we have worked on carries a story, and the land here does not forgive neglect. Our responsibility has always been to leave each site in better shape than we found it. That standard has not changed, and it will not change.” Those words reflect the values that have shaped the company since its founding.
Trust in a service provider is earned over time, not announced. Across Sutton County and Crockett County, residents have come to rely on Borders Tree Services because the company consistently delivers on its word. Homeowners in the Eaton Hill area and along Crockett Avenue schedule seasonal trimming without hesitation. Ranchers near Rocksprings and Eden call for large-scale removal after storm seasons. Property owners throughout the region know the crew will arrive on time, work with care, and leave the site clean. That reputation, built over 15 years of showing up and getting the job done, is what the company is celebrating.
About Borders Tree Services
Borders Tree Services is a Sonora-based tree service company with 15 years of experience serving the Edwards Plateau region. The company provides tree trimming, removal, stump grinding, cutting, and emergency response.
The post Borders Tree Services Marks 15 Years Serving Sutton and Crockett County, TX appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
Drug education initiative supported by the Church of Scientology opens its 2026 Dublin activities at the Connect Multicultural Festival in Blanchardstown
Brussels, Brussels, Belgium, 21st May 2026 — A mobile exhibition dedicated to drug education and prevention was launched in Dublin as part of the 2026 activities of The Truth About Drugs, a secular educational campaign supported by the Church of Scientology and Scientologists.
The exhibition, first reported by GNN24x7 Ireland, opened during the Connect Multicultural Festival, held at Millennium Park in Blanchardstown. The Fingal community celebration brought together families, cultural groups and residents through music, food, art and public activities, offering a visible setting for the prevention message.
The mobile exhibit presented simple, factual information on the effects of drugs, with free educational materials intended to help people make informed decisions. Volunteers provided booklets and answered questions from visitors, many of whom stopped to learn more about drug prevention in a public and accessible format.
The Dublin initiative forms part of the international Truth About Drugs campaign, supported by the Church of Scientology and inspired by the words of Scientology founder L. Ron Hubbard: “The single most destructive element present in our culture is drugs.” Through the Foundation for a Drug-Free World, the campaign makes educational booklets, audiovisual materials and prevention resources available to schools, community organisations and public groups.
The Church of Scientology describes the campaign as part of its wider social betterment work, with drug prevention education presented as a practical contribution to communities. Its background is also set out in the Church’s information on Creating a Drug-Free World, which links the initiative to decades of educational activity by Scientologists.
The subject remains of clear public relevance in Ireland. The Health Research Board reported that 354 drug poisoning deaths were recorded in Ireland in 2021. Its findings identified opioids, benzodiazepines and antidepressants as the most common drug groups implicated in poisoning deaths overall, while cocaine and heroin were among the most common illicit drugs involved.
Against that background, local volunteers said the Dublin exhibition was designed to contribute to prevention through education, not alarmism. Its emphasis was on understandable information, early awareness and personal responsibility, particularly in communities where families and young people are seeking clear, non-technical resources.
Ivan Arjona, representative of the Church of Scientology to the European Union, the OSCE, the Council of Europe and the United Nations, said the Dublin event reflected a practical approach to civic responsibility:
“Drug prevention is not only a health question; it is also a question of human dignity, education and community resilience,” said Arjona. “Across Europe, societies are strongest when citizens, families, schools and community groups work together to give young people truthful information before harm occurs. This is the spirit behind the Church of Scientology’s support for The Truth About Drugs campaign.”
The Church of Scientology & Community Centre of Dublin has previously supported community-based educational and social betterment initiatives, including drug prevention, human rights education and volunteer activities. The Dublin mobile exhibition continues that local work by placing educational material directly in public spaces where people naturally gather.
The Truth About Drugs campaign is presented as a secular initiative. Its materials are used internationally by volunteers and community partners seeking to address drug abuse through prevention and factual education. The campaign’s public materials describe its purpose as empowering young people and adults with factual information about drugs so they can make informed choices.
The Dublin exhibition also connected with the broader civic spirit of the Connect Multicultural Festival. In a setting designed to celebrate diversity and shared community life, the prevention message was framed as a contribution to safer neighbourhoods and stronger social cooperation.
Organisers said the mobile exhibition will continue to serve as a practical platform for public education during 2026, bringing materials to locations where community engagement can help make prevention more visible, accessible and personal.
The Church of Scientology, its churches, missions, groups and members are present across the European continent. Scientology Europe reports a continent-wide presence through more than 140 churches, missions and affiliated groups in at least 27 European nations, alongside thousands of community-based social betterment and reform initiatives focused on education, prevention and neighbourhood-level support, inspired by the work of Scientology founder L. Ron Hubbard.
Within Europe’s diverse national frameworks for religion, the Church’s recognitions continue to expand, with administrative and judicial authorities in Spain, Portugal, Sweden, the Netherlands, Italy, Germany, Slovakia and others, as well as the European Court of Human Rights, having addressed and acknowledged Scientology communities as protected by the national and international provisions of Freedom of Religion or belief.
Media Contact
Organization: European Office Church of Scientology for Public Affairs and Human Rights
The post Mobile Exhibition Brings Truth About Drugs Prevention to Dublin appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
New York, United States, 21st May 2026 — Bitamp continues to reinforce its position in the cryptocurrency space by providing a secure, privacy-focused Bitcoin wallet built on client-side technology. As demand for self-custody solutions grows, the platform delivers a browser-based wallet experience that enables users to create and manage Bitcoin wallets independently.
Built with privacy at its core, Bitamp Bitcoin wallet enables users to create wallets without registration, identity verification, or the submission of personal information. This simplified approach allows individuals to access and manage Bitcoin directly while maintaining greater privacy and independence throughout the process.
“Privacy and self-custody are becoming essential for Bitcoin users worldwide,” said a spokesperson for Bitamp. “Our goal is to provide a secure and transparent wallet experience that gives users complete control over their digital assets without unnecessary barriers or third-party dependence.”
Bitamp’s non-custodial framework reflects the broader shift toward self-custody solutions within the cryptocurrency industry. By allowing users to remain fully responsible for their private keys and recovery details, the platform supports direct ownership of digital assets while aligning with Bitcoin’s decentralized principles.
Accessibility remains another important advantage. Because Bitamp works directly within the browser, users do not need to install software or complete complicated setup procedures. This makes wallet creation and management accessible for both new Bitcoin users and experienced holders seeking a simple and secure solution.
About Bitamp
Bitamp is an open-source, client-side Bitcoin wallet designed to provide secure and private access to Bitcoin without registration or personal data collection. Built on a non-custodial framework, the platform enables users to generate and manage wallets directly in their browser while maintaining full control of their private keys.
Landmarq Tree Service has marked a major milestone of a quarter-century in business throughout Passaic and Morris County this month. They provide essential safety and tree maintenance solutions for residential and commercial property owners across the region.
Wayne, New Jersey 07470, United States, 21st May 2026 – Homeowners in northern New Jersey face unique property challenges due to aging oak forests and unpredictable coastal storms. High winds and heavy ice frequently cause massive limbs to threaten homes or block local roadways. Landmarq Tree Service stepped up decades ago to address these specific safety hazards for the community. The team understands how the local clay loam and glacial till soils impact root stability. They focus on preventing property damage before it happens by identifying structural weaknesses in mature maples and pines. This proactive approach helps residents avoid the high costs of emergency repairs after severe weather hits.
The company delivers solutions through a combination of traditional hard work and modern safety standards. Their tree care professionals handle everything from technical removals to routine pruning that promotes long-term health. Over the last twenty-five years, they have built a reputation based on reliability and transparent pricing. Key features of their service include 100% satisfaction guarantees and on-staff qualified arborists. They offer stump grinding and emergency response to ensure a property remains functional and attractive. By maintaining full licensing and insurance, they protect every client from the liability risks often associated with dangerous high-elevation work.
“Our goal has always been to provide the highest level of safety for our neighbors,” a senior team member stated. “Reaching twenty-five years proves that the community values honest work and thorough cleanup. We treat every yard as if it were our own property. We look forward to another two decades of keeping local families safe from hazardous trees.” This commitment to service quality remains the central focus of the daily operations. The staff continues to refine their techniques to meet the evolving needs of modern suburban landscapes.
Local residents trust the team because they see consistent results and a spotless finish on every job site. Clients appreciate their free estimates that prevent surprise fees at the end of a project. By consistently delivering professional results, the business has earned over forty five-star reviews from satisfied property owners. This track record makes them a primary choice for anyone looking to protect their home investment.
About Landmarq Tree Service
Landmarq Tree Service is a family-owned provider specializing in residential and commercial tree care. With twenty-five years of experience, they offer expert removal, trimming, and emergency services. The company prides itself on 100% satisfaction guarantees, experienced staff, and a reputation for excellence throughout the Passaic and Morris County areas.
While the global digital health industry remains focused on specification-driven competition and fragmented use cases, LingSense Bio, a rising Chinese medtech innovator, chose Silicon Valley as the stage to present its answer.
At the “BEYOND SLEEP: THE STAREEP PREMIERE” global launch event, LingSense Bio, official medical health partner of smart sleep brand Stareep, made its international debut, introducing a comprehensive, closed-loop health management solution that integrates hardware, software, and AI services. This innovation aims to redefine healthcare standards for billions of chronic disease patients worldwide.
LingSense Bio’s wearable product lineup made a stunning debut
The LingSense Bio Ecosystem Ushers in an All in One AI Era of Seamless Monitoring
With the global chronic disease management market expanding rapidly into a trillion-dollar industry, Faris Li, Head of Product at LingSense Bio, delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.” His assessment was direct: “Hardware alone cannot solve the challenges of chronic disease management. Without AI-driven intervention, health data is just a pile of numbers.”
Faris highlighted that while over 626 million people suffer from cardiovascular diseases and 830 million live with diabetes globally, continuous glucose monitoring (CGM) penetration among type 2 diabetes patients remains below 10%. Furthermore, dynamic blood pressure monitoring has long been constrained by traditional cuff-based devices. “Patients need unobtrusive, continuous, and precise monitoring, not fragmented occasional readings,” Faris emphasized. The future of medical-grade wearables, he noted, lies in two key trends: multi-parameter “All-in-One” integration and deep AI embedding from edge to platform.
To address these needs, LingSense Bio has developed a product matrix. Faris Li showcased two groundbreaking core hardware innovations:
Continuous Glucose Monitor (CGM): Boasting an industry-leading MARD (Mean Absolute Relative Difference) of under 8.0%, rivaling top-tier global brands.
Wearable dynamic Blood Pressure Monitor (dBP): The world’s first wearable dBP powered by Tonoarteriography (TAG) technology, developed by Professor Yuan-Ting Zhang’s team, delivering medical-grade continuous blood pressure tracking.
LingSense Bio also introduced LingWatch Pro, a smart watch with dynamic blood pressure monitoring; LingRing Nexus R1, a smart ring integrating non-invasive blood glucose trend monitoring, PPG, blood oxygen, temperature, and heart rate variability (HRV) monitoring; and LingCare SpringMini, a portable oxygen concentrator designed to provide stable oxygen supply at altitudes of up to 6,000 meters.
These devices function as specialized physiological sensors that stream data into the LingSense Chronic Disease Management Platform, forming a closed-loop ecosystem covering glucose, blood pressure, blood oxygen, and ECG.
Faris Li delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.”
Professor Yuan-Ting Zhang: Three Decades of Cuffless Innovation Reach Industrial Standard Moment
At the event, Professor Yuan-Ting Zhang, a Fellow of the International Academy for Medical and Biological Engineering, delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.” With over 30 years of pioneering research in cuffless blood pressure monitoring, Academician Zhang shared clinical insights and engineering philosophies that underscore the team’s forward-looking approach to digital cardiovascular health.
Professor Zhang pointed out that traditional blood pressure monitoring fails to capture critical nocturnal data. Clinical follow-ups from the Dublin Hypertension Clinic show that nighttime hypertension is highly correlated with a 5-year risk of cardiovascular mortality, and increased blood pressure variability serves as an independent warning sign. “However, traditional cuff-based devices cannot frequently inflate while a patient is sleeping without disrupting their rest,” Professor Zhang noted, highlighting the necessity of cuffless wearable technology. The deep learning models developed by his team for systolic and diastolic measurements have already achieved Grade A performance under IEEE, AAMI, and BHS standards.
Professor Yuan-Ting Zhang delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.”
The “dBP” solution represents a new era of 24/7 health management. By fusing physiological sensing, intelligent algorithms, and continuous data analysis, it offers a natural, low-burden monitoring experience. “The dBP focuses on long-term health trends rather than isolated readings,” Professor Zhang explained. “By analyzing continuous data streams, the system can provide valuable clinical insights for diagnosing masked hypertension, nocturnal anomalies, and evaluating chronic disease risks.”
Notably, Daniel Franklin, an Assistant Professor in the Institute of Biomedical Engineering at the University of Toronto, traveled to Silicon Valley as a specially invited international guest for the event. He participated in a session themed “Technology & Healthy Sleep,” where he engaged in an in-depth academic dialogue with fellow attendees. Known for his work in bio-integrated electronics and soft-matter photonics, Franklin offered an independent, clinically informed perspective on the event’s most anticipated innovation, the wearable dynamic blood pressure (dBP) monitoring technology.
Daniel Franklin participated in a session themed “Technology & Healthy Sleep” and shared in-depth academic insights
Data from LingSense Bio’s wearable product matrix, including CGM readings, ambulatory blood pressure data, blood oxygen saturation, and ECG signals, will be synchronized in real time to the LingSense Chronic Disease Management Platform. Built on LingSense Bio’s self-developed, medical-grade AI large model, the platform analyzes continuous health data and identifies potential risk patterns. It further incorporates Dr. PAI (Personalized AI Doctor), the world’s first hypertension intelligent management platform that combines a wearable dynamic blood pressure monitoring device, an AI health assistant avatar, and a large language model, developed by the team led by Professor Zhang. Together, they deliver a closed-loop experience spanning AI-powered consultation, health assessment, blood pressure pattern recognition, and personalized health management recommendations.
In January 2026, the U.S. Food and Drug Administration (FDA) officially released the draft guidance titled “Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation,” marking a long-awaited standard for the industrialization of a technology nearly three decades in the making. Professor Zhang’s team has been deeply involved in the development of both the FDA draft guidance and the relevant IEEE standard; the IEEE standard led by his team has already been adopted by the FDA as a reference. “The world is embracing this standard, and LingSense is ready to be tested,” Professor Zhang said.
A China-Born Solution for Global Standards
As the Silicon Valley sun cast its glow over Stanford, LingSense Bio’s brand logo lit up across the giant screen. Without complicated regulatory language or excessive marketing rhetoric, LingSense had already delivered its message: connecting China’s precision with the world’s broader healthcare needs.
From CGM systems with an MARD below 8.0% to the medical-grade continuous wearable blood pressure monitor dBP, LingSense Bio is challenging a market long dominated by industry giants like Dexcom and Abbott. But for chronic disease patients around the world, the most meaningful takeaway from this launch may be what LingSense Bio President Zhifeng Peng put most simply: “Whether you live in a major city or a remote village, expert-level personal healthcare should not be a privilege.” This China-born solution, making its debut in Silicon Valley, is now accelerating onto the global stage.
Media Contact
Organization: LingSense Bio (Shenzhen) Technology Co., Ltd.
